马来酸氯苯那敏BP2015翻译

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Chlorphenamine Maleate

马来酸氯苯那敏

General Notices

总体概述

(Ph. Eur. monograph 0386)

C20H23ClN2O4 390.9 113-92-8

Action and use

使用及用途

Histamine H1 receptor antagonist; antihistamine.

组胺H1受体拮抗剂;抗组胺药。

Preparations

制剂

Chlorphenamine Injection

马来酸氯苯那敏注射液

Chlorphenamine Oral Solution

马来酸氯苯那敏口服溶液

Chlorphenamine Tablets

马来酸氯苯那敏片

Ph Eur

DEFINITION

定义

(3RS)-3-(4-Chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine hydrogen (Z)- butenedioate.

(3RS)-3-(4-氯苯基)-N,N-二甲基-3 -(2-吡啶基)丙烷-1-胺氢(Z)—butenedioate。Content

含量

98.0 per cent to 101.0 per cent (dried substance).

98.0~101.0%(按干燥品计算)

CHARACTERS

性状

Appearance

外观

White or almost white, crystalline powder.

白色或类白色结晶性粉末

Solubility

溶解度

Freely soluble in water, soluble in ethanol (96 per cent).

易溶于水,溶于乙醇(96.0%)

IDENTIFICATION

鉴别

A. Melting point (2.2.14): 130 °C to 135 °C.熔点(2.2.14)130℃-135℃

B. Infrared absorption spectrophotometry (2.2.24).Comparison chlorphenamine maleate CRS. 红外光吸收光谱(2.2.24)与马来酸氯苯那敏的对照品一致

C. Optical rotation (see Tests).旋光度(见测试)

TESTS

测试

Solution S

溶液澄清度与颜色(溶液S)

Dissolve 2.0 g in water R and dilute to 20.0 mL with the same solvent.

取供试品2.0g,置于20ml容量瓶中,用水溶解并稀释至刻度。

Appearance of solution溶液外观

Solution S is clear (2.2.1) and not more intensely coloured than reference solution BY6(2.2.2, Method II).溶液S应澄清无色;如显色,与BY6比较不得更深。

Optical rotation (2.2.7)旋光度

-0.10° to + 0.10°, determined on solution S.-0.10°-+0.10°,用溶液S测定

Related substances有关物质

Liquid chromatography (2.2.29).高效液相色谱法(2.2.29)

Test solution Dissolve 0.100 g of the substance to be examined in the mobile phase and dilute to 100.0 mL with the mobile phase.

供试品溶液:精密称取供试品0.100g,置100ml容量瓶中,用流动相溶解并定量稀释至刻度,即得。

Reference solution (a) Dilute 0.5 mL of the test solution to 100.0 mL with the mobilephase.

对照溶液a:精密量取供试品溶液0.5ml置100ml容量瓶中,用流动相定量并稀释至刻度,即得。

Reference solution (b) Dilute 1.0 mL of reference solution (a) to 10.0 mL with the mobile phase.

对照溶液b:精密量取对照溶液a1.0ml,置10ml容量瓶中,用流动相定量并稀释至刻度,即得。

Reference solution (c) Dissolve 5 mg of chlorphenamine impurity C CRS in 5 mL of the test solution and dilute to 50.0 mL with the mobile phase. Dilute 2 mL of this solutionto 20 mL with the mobile phase.

对照溶液c:精密量取杂质C 对照品5mg,置50.0ml容量瓶中,用5ml的供试品溶液溶解,加入流动相溶解并稀释至刻度,摇匀。再取该溶液2ml置20ml容量瓶中,并用流动相溶解并稀释至刻度,即得。

Reference solution (d) Dissolve 5 mg of 2,2¢-dipyridylamine R (impurity B) in the mobile phase and dilute to 100 mL with the mobile phase.

对照溶液d:精密量取5mg的杂质B 置100ml的容量瓶中,用流动相溶解并定量稀释至刻度即得。

Reference solution (e) Dissolve the contents of a vial of chlorphenamine impurity A CRS in 2 mL of the test solution. Sonicate for 5 min.

对照溶液e:精密量取含有杂质A的对照品,用2ml的供试品溶液溶解,超声5分钟。Column:柱

—size: l = 0.30 m, Ø = 3.9 mm;尺寸

相关文档
最新文档